Clinical Trial Update: Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update involving glimepiride, alogliptin, and alogliptin+pioglitazone for Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Glimepiride (glimepiride)
• alogliptin+pioglitazone combination (alogliptin and pioglitazone combination)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN